These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 18359028)

  • 1. High-sensitivity C-reactive protein levels in HIV-infected patients treated or not with antiretroviral drugs and their correlation with factors related to cardiovascular risk and HIV infection.
    Guimarães MM; Greco DB; Figueiredo SM; Fóscolo RB; Oliveira AR; Machado LJ
    Atherosclerosis; 2008 Dec; 201(2):434-9. PubMed ID: 18359028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultrasonographic measurement of intra-abdominal fat thickness in HIV-infected patients treated or not with antiretroviral drugs and its correlation to lipid and glycemic profiles.
    Guimarães MM; de Oliveira AR; Penido MG; Queiroz LC; Goulart EM; Greco DB; Machado LJ
    Ann Nutr Metab; 2007; 51(1):35-41. PubMed ID: 17356264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of antiretroviral therapy on oxidative stress and cardiovascular risk: a prospective cross-sectional study in HIV-infected patients.
    Masiá M; Padilla S; Bernal E; Almenar MV; Molina J; Hernández I; Graells ML; Gutiérrez F
    Clin Ther; 2007 Jul; 29(7):1448-55. PubMed ID: 17825696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of C-reactive protein as a marker for cardiovascular risk associated with antiretroviral therapy in HIV-infected patients.
    Masiá M; Bernal E; Padilla S; Graells ML; Jarrín I; Almenar MV; Molina J; Hernández I; Gutiérrez F
    Atherosclerosis; 2007 Nov; 195(1):167-71. PubMed ID: 17049532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time to viral load suppression in antiretroviral-naive and -experienced HIV-infected pregnant women on highly active antiretroviral therapy: implications for pregnant women presenting late in gestation.
    Aziz N; Sokoloff A; Kornak J; Leva NV; Mendiola ML; Levison J; Feakins C; Shannon M; Cohan D
    BJOG; 2013 Nov; 120(12):1534-47. PubMed ID: 23924192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular disease risk factors in HIV patients--association with antiretroviral therapy. Results from the DAD study.
    Friis-Møller N; Weber R; Reiss P; Thiébaut R; Kirk O; d'Arminio Monforte A; Pradier C; Morfeldt L; Mateu S; Law M; El-Sadr W; De Wit S; Sabin CA; Phillips AN; Lundgren JD;
    AIDS; 2003 May; 17(8):1179-93. PubMed ID: 12819520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of leukocyte count and hsCRP with metabolic abnormalities in subjects with normal glucose tolerance (CURES - 64).
    Gokulakrishnan K; Deepa R; Sampathkumar R; Balasubramanyam M; Mohan V
    J Assoc Physicians India; 2009 Jan; 57():27-32. PubMed ID: 19753755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum ferritin in HIV-positive patients is related to immune deficiency and inflammatory activity.
    López-Calderón C; Palacios R; Cobo A; Nuño E; Ruiz J; Márquez M; Santos J
    Int J STD AIDS; 2015 May; 26(6):393-7. PubMed ID: 24912540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of metabolic syndrome in HIV-infected patients receiving highly active antiretroviral therapy using International Diabetes Foundation and Adult Treatment Panel III criteria: associations with insulin resistance, disturbed body fat compartmentalization, elevated C-reactive protein, and [corrected] hypoadiponectinemia.
    Samaras K; Wand H; Law M; Emery S; Cooper D; Carr A
    Diabetes Care; 2007 Jan; 30(1):113-9. PubMed ID: 17192343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic syndrome in French HIV-infected patients: prevalence and predictive factors after 3 years of antiretroviral therapy.
    Biron A; Bobin-Dubigeon C; Volteau C; Piroth L; Perré P; Leport C; Prazuck T; Jovelin T; Billard M; Sébille V; Bard JM; Raffi F; Biron C
    AIDS Res Hum Retroviruses; 2012 Dec; 28(12):1672-8. PubMed ID: 22731114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes of metabolic and inflammatory markers in HIV infection: glucose, lipids, serum Hs-CRP and myeloperoxidase.
    Borato DC; Parabocz GC; Ribas SR; Kalva-Filho CA; Borba LM; Ito CA; Bail L; dos Santos FA; Vellosa JC
    Metabolism; 2012 Oct; 61(10):1353-60. PubMed ID: 22480983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiretroviral therapy affects the composition of weight loss in HIV infection: implications for clinical nutrition.
    Maia BS; Engelson ES; Wang J; Kotler DP
    Clin Nutr; 2005 Dec; 24(6):971-8. PubMed ID: 16095765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-sensitivity C-reactive protein is only weakly related to cardiovascular damage after adjustment for traditional cardiovascular risk factors.
    Olsen MH; Christensen MK; Hansen TW; Gustafsson F; Rasmussen S; Wachtell K; Borch-Johnsen K; Ibsen H; Jørgensen T; Hildebrandt P
    J Hypertens; 2006 Apr; 24(4):655-61. PubMed ID: 16531793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonalcoholic fatty liver disease in HIV-infected patients referred to a metabolic clinic: prevalence, characteristics, and predictors.
    Guaraldi G; Squillace N; Stentarelli C; Orlando G; D'Amico R; Ligabue G; Fiocchi F; Zona S; Loria P; Esposito R; Palella F
    Clin Infect Dis; 2008 Jul; 47(2):250-7. PubMed ID: 18532884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fasting blood glucose and insulin sensitivity are unaffected by HAART duration in Cameroonians receiving first-line antiretroviral treatment.
    Ekali LG; Johnstone LK; Echouffo-Tcheugui JB; Kouanfack C; Dehayem MY; Fezeu L; Nouthe B; Hayes L; Unwin NC; Sobngwi E
    Diabetes Metab; 2013 Feb; 39(1):71-7. PubMed ID: 23153435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis C infection is associated with lower lipids and high-sensitivity C-reactive protein in HIV-infected men.
    Floris-Moore M; Howard AA; Lo Y; Schoenbaum EE; Arnsten JH; Klein RS
    AIDS Patient Care STDS; 2007 Jul; 21(7):479-91. PubMed ID: 17651029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of the metabolic syndrome insulin resistance and the atherosclerotic diseases in Africans infected by Helicobacter pylori infection and treated by antibiotics.
    Longo-Mbenza B; Nkondi Nsenga J; Vangu Ngoma D
    Int J Cardiol; 2007 Oct; 121(3):229-38. PubMed ID: 17368586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short communication: contribution of the immunovirological state and traditional cardiovascular risk factors to low HDL-cholesterol in HIV patients.
    Palacios R; Puerta S; Orihuela F; Olalla J; Roldán J; Grana M; Márquez M; Colmenero JD; Santos J;
    AIDS Res Hum Retroviruses; 2010 Nov; 26(11):1167-70. PubMed ID: 20929391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction in circulating markers of endothelial dysfunction in HIV-infected patients during antiretroviral therapy.
    Kristoffersen US; Kofoed K; Kronborg G; Giger AK; Kjaer A; Lebech AM
    HIV Med; 2009 Feb; 10(2):79-87. PubMed ID: 19200170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Corporal fat distribution and lipidic and glicemic profiles of HIV-infected patients].
    Guimarães MM; Greco DB; de O Júnior AR; Penido MG; Machado LJ
    Arq Bras Endocrinol Metabol; 2007 Feb; 51(1):42-51. PubMed ID: 17435854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.